These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Platelet glycoprotein IIb/IIIa receptor blockade with integrilin (eptifibatide) for early postinfarction angina in a patient with coronary arterial ectasia. Grigorov V; Goldberg L; Mekel J Cardiovasc J S Afr; 2002; 13(3):125-8. PubMed ID: 12193965 [TBL] [Abstract][Full Text] [Related]
3. Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. Lauer MA; Houghtaling PL; Peterson JG; Granger CB; Bhatt DL; Sapp SK; Simoons ML; Harrington RA; Topol EJ; Lincoff AM; Circulation; 2001 Dec; 104(23):2772-7. PubMed ID: 11733393 [TBL] [Abstract][Full Text] [Related]
4. Randomized evaluation of the efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Long-term results of the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) trial. Fitchett DH; Langer A; Armstrong PW; Tan M; Mendelsohn A; Goodman SG; Am Heart J; 2006 Feb; 151(2):373-9. PubMed ID: 16442903 [TBL] [Abstract][Full Text] [Related]
5. Eptifibatide in acute coronary syndromes. Levin T N Engl J Med; 1999 Jan; 340(1):60; author reply 61. PubMed ID: 9882213 [No Abstract] [Full Text] [Related]
6. Contemporary view of the acute coronary syndromes. Moustapha A; Anderson HV J Invasive Cardiol; 2003 Feb; 15(2):71-9. PubMed ID: 12556619 [No Abstract] [Full Text] [Related]
15. Design and methodology of the PURSUIT trial: evaluating eptifibatide for acute ischemic coronary syndromes. Platelet Glycoprotein IIb-IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. Harrington RA Am J Cardiol; 1997 Aug; 80(4A):34B-38B. PubMed ID: 9291244 [TBL] [Abstract][Full Text] [Related]
16. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Fernandez JS; Sadaniantz A Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658 [No Abstract] [Full Text] [Related]
17. Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines. Mehta SR; J Invasive Cardiol; 2002 Dec; 14 Suppl E():27E-34E; quiz 35E. PubMed ID: 12668860 [TBL] [Abstract][Full Text] [Related]
18. Unstable angina and non-ST-segment elevation myocardial infarction: perspectives on combination therapy. Villareal RP; Kim P; Ferguson JJ; Wilson JM Tex Heart Inst J; 2001; 28(4):276-87. PubMed ID: 11777152 [TBL] [Abstract][Full Text] [Related]
19. Refining the treatment of women with unstable angina--a randomized, double-blind, comparative safety and efficacy evaluation of Integrelin versus aspirin in the management of unstable angina. Goldschmidt-Clermont PJ; Schulman SP; Bray PF; Chandra NC; Grigoryev D; Dise KR; Sagar M; Fox RJ; Coleman LD; Richardson C; Dorsey FC; du Mee C; Kitt MM; Ouyang P; Baughman KL; Gerstenblith G Clin Cardiol; 1996 Nov; 19(11):869-74. PubMed ID: 8914780 [TBL] [Abstract][Full Text] [Related]